Hippocampal rhythms in clock gene expression, enzymatic activity, and long-term potentiation (LTP) are thought to underlie day-night differences in memory acquisition and recall. Glycogen synthase kinase 3-beta (GSK3b) is a known regulator of hippocampal function, and inhibitory phosphorylation of GSK3b exhibits region-specific differences over the light-dark cycle. Here, we sought to determine whether phosphorylation of both GSK3a and GSK3b isoforms has an endogenous circadian rhythm in specific areas of the hippocampus and whether chronic inhibition or activation alters the molecular clock and hippocampal plasticity (LTP). Results indicated a significant endogenous circadian rhythm in phosphorylation of GSK3b, but not GSK3a, in hippocampal CA1 extracts from mice housed in constant darkness for at least 2 weeks. To examine the importance of this rhythm, genetic and pharmacological strategies were used to disrupt the GSK3 activity rhythm by chronically activating or inhibiting GSK3. Chronic activation of both GSK3 isoforms in transgenic mice (GSK3-KI mice) diminished rhythmic BMAL1 expression. On the other hand, chronic treatment with a GSK3 inhibitor significantly shortened the molecular clock period of organotypic hippocampal PER2::LUC cultures. While WT mice exhibited higher LTP magnitude at night compared to day, the day-night difference in LTP magnitude remained with greater magnitude at both times of day in mice with chronic GSK3 activity. On the other hand, pharmacological GSK3 inhibition impaired day-night differences in LTP by blocking LTP selectively at night.
2008). In addition, Per2 mutants exhibit deficits in trace-fear conditioning, and synaptic plasticity (Wang et al., 2009 ). Finally, Bmal12/2 mice display initial hyperactivity and impaired intrasession and intersession habituation to a novel environment, suggesting a deficit in short-and long-term contextual memory formation (Kondratova, Dubrovsky, Antoch, & Kondratov, 2010) . More recently, mice with forebrainspecific Bmal1 knockout were shown to have impaired Barnes maze performance and novel object location memory (Snider et al., 2016) .
These findings indicate that the circadian clock is involved in learning and memory processes, including synaptic plasticity. However, the clock-driven molecular mechanisms underlying diurnal differences in hippocampal plasticity and memory are not well understood.
A potential candidate regulator of day-night changes in hippocampal function is glycogen synthase kinase (GSK3), a serine/threonine kinase with two isoforms (GSK3a and GSK3b) that exhibit daily rhythms in phosphorylation (inactivation) in the brain (Besing et al., 2015; Iitaka, Miyazaki, Akaike, & Ishida, 2005; Iwahana et al., 2004; Kinoshita, Miyazaki, & Ishida, 2012) . Several lines of evidence suggest that GSK3 also modulates activity-dependent synaptic plasticity in the hippocampus (Peineau et al., 2008) . After induction of long-term potentiation (LTP), phosphorylation of GSK3 (p-GSK3) is elevated, indicating that LTP is associated with GSK3 inactivation (Hooper et al., 2007; Peineau et al., 2007) . Furthermore, overexpression of GSK-3b in mouse cortical and hippocampal neurons significantly decreases LTP magnitude which is reversed by treatment with lithium chloride, a known GSK3 inhibitor (Hooper et al., 2007) . Another form of plasticity, long-term depression (LTD), is blocked by pharmacological GSK3 inhibition (Peineau et al., 2007) . Last, overexpression or enhanced activation of GSK3 in rodents is associated with impaired Morris water maze performance, which is reversed by lithium chloride (Hernandez, Borrell, Guaza, Avila, & Lucas, 2002; Liu et al., 2003) . These studies suggest that GSK3 may bidirectionally modulate two major forms of activitydependent synaptic plasticity that are important for learning and memory processes.
Although p-GSK3b levels in hippocampus vary across the lightdark cycle (Kinoshita et al., 2012) , it is not clear how these levels change in specific hippocampal subfields, whether phosphorylation of the GSK3a isoform shows daily variation, and/or whether these hippocampal oscillations are light-driven. These rhythms are likely to impact hippocampal function and plasticity. Therefore, we sought to test the hypothesis that the circadian variation in the phosphorylation state balance of GSK3a/b in hippocampus is critical for normal periodicity of the molecular clock and day/night differences in LTP. Through genetic and pharmacological alterations of GSK3 activity, we show that GSK3 activation modulates hippocampal function in a time-of-day-dependent manner.
| MATERIALS A ND METHODS

| Animals
Male, wild-type (WT) C57-BL6/J mice (generated within our colony or purchased from Jackson Laboratories, Bar Harbor, ME, USA) were age matched to male, GSK3a/b 21A/21A/9A/9A (GSK3-KI) mice (2-5 months old) backcrossed for at least 10 generations to C57BL/6 mice. GSK3-KI mice have serine-alanine substitutions (S9 and S21) on both GSK3 isoforms, rendering GSK3 dephosphorylated and constitutively active (McManus et al., 2005) . Both mutations are necessary to disrupt circadian activity rhythms (Paul, Johnson, Jope, & Gamble, 2012) . Male,
Per2
Luc1/2 knock-in mice (16-60 days old) backcrossed to C57BL/6 for 12 generations (Yoo et al., 2004) were used to measure PER2-driven luminescence. In general, animals were group-housed in a 12:12 light/dark (LD) cycle with the exception of animals used for western blot analysis of rhythms in constant darkness (DD). These animals were housed individually in cages equipped with running wheels (Coulbourn Instruments, Whitehall, PA, USA), and wheel-running activity was recorded and analyzed using ClockLab software (Actimetrics, Wilmette, IL). Mice were housed in DD for at least 14 days before being sacrificed via cervical dislocation and rapid decapitation at circadian times (CTs) determined by locomotor activity rhythms (where CT12 equals activity onset and the beginning of subjective night). All animals had access to food and water ad libitum and were handled in accordance with the University of Alabama at Birmingham (UAB) Institutional Animal Care and Use Committee (IACUC) and National Institutes of Health (NIH) guidelines.
| Protein extraction and Western blotting
Protein extraction and Western blotting were carried out as previously described (Besing et al., 2015) . For densitometry, normalization included two steps. First, for each blot/time course (4-6 replicates per ZT), both bands for the protein of interest and the loading control protein at each ZT time were divided by the bands for the positive control sample, which was a single sample of whole-brain homogenate that was included on each blot (allowing comparison between blots). Second, for each sample, the normalized protein of interest was divided by the normalized loading control for each sample (i.e., p-GSK3a/b and BMAL1 were normalized to total GSK3a/b and a-Tubulin loading controls, respectively; as in (Franklin et al., 2013; Sahar, Zocchi, Kinoshita, Borrelli, & Sassone-Corsi, 2010) Hippocampal slice preparation and electrophysiological recordings.
Mice were euthanized using cervical dislocation followed by rapid decapitation. Brains were removed and placed in ice-cold "high- (Reymann & Frey, 2007) . This strategy is similar to that used in a previous study that demonstrated a day/night difference in LTP magnitude in mice (Chaudhury et al., 2005) . Slices were perfused with either CHIR-99021 (2.0 mM; Stemgent) or vehicle (DMSO; 0.04%) for at least 20 min prior to high-frequency stimulation (HFS) and for the duration of the recordings.
| Statistical analysis
All statistical comparisons were made in SPSS software (version 22), and alpha (Type I error) was set at 0.05. For analysis of the western blot experiments, significant rhythmicity was determined using cosinor analysis. A nonlinear regression was run using the following equation: F tests were used for post-hoc analysis.
Expression of core clock genes oscillates in nearly every cell, including those in hippocampus (Jilg et al., 2010) . Thus, the molecular clock may also drive phosphorylation of GSK3 in hippocampus. Therefore, we quantified the phosphorylated/total GSK3b ratio every 4 hr over a 24 hr period in a light:dark (LD) cycle. A statistically significant rhythm was evident for area CA1 (n 5 23/time course; cosinor analysis, Figure 1a ), but not for the dentate gyrus (n 5 22/time course; F (2, 19) 5 1.98, p 5 .17; data not shown). We next tested the hypothesis that the 24 hr variation of GSK3 phosphorylation (for both GSK3a and GSK3b isoforms) in area CA1 persists in constant conditions. The CA1 regions of mice housed in constant dark (DD) for 2 weeks were isolated across a 24 hr period, and cosinor nonlinear regression analysis of p-GSK3b levels revealed a significant 24 hr rhythm where phosphorylation is increased during the subjective day and decreased during subjective night, corresponding to higher GSK3 activation during the night compared to day (n 5 28/time course; R 2 5 0.21, F (2, 25) 5 3.37 p 5 .05; Figure 1b) . Interestingly, the p-GSK3b rhythm was delayed compared to the primary circadian clock in the SCN (Besing et al., 2015) and peaked in the middle of the subjective day under DD conditions (mesor, 0.84 6 .08; amplitude, 0.29 6 0.11; phase, CT 5.74 6 1.67; Figure 1a ). In contrast to GSK3b, quantification of the p-GSK3a/total GSK3a ratio in CA1 did not reveal a significant rhythm (n 5 27/time course; cosinor nonlinear regression analysis, R 2 5 0.035, F (2, 24) 5 0.43, p 5 .65; Figure 1c ), such that rhythmic phosphorylation of GSK3 in area CA1 was specific to the GSK3b isoform only. Similar to the SCN (Besing et al., 2015) , total GSK3a and GSK3b levels in hippocampus were stable across the 24 hr day (R.C.
Besing, unpublished observations).
| GSK3 regulates the molecular circadian clock in hippocampus
To examine whether the rhythm of GSK3 inactivation is necessary for normal periodicity of the molecular clock in the hippocampus, we investigated the effects of chronic GSK3 inhibition using a real-time, read out of the molecular clock via the widely used Period2 luciferase (mPer2
) mouse model (Wang et al., 2009; Yoo et al., 2004) . Quantification (top; n 5 22 or 28/time course, respectively; mean 6 SEM per ZT or CT bin, respectively) and representative western blots (bottom) of the p-GSK3b to total GSK3b ratio. (c) Quantification (top; n 5 27/time course; mean 6 SEM per CT bin) and representative western blots (bottom) of p-GSK3a to total GSK3a ratio. Lines indicate the significant cosinor function fit (Besing et al., 2015) , using a transgenic mouse model in which serinealanine mutations render both isoforms of GSK3 constitutively active (GSK3-KI) but at endogenous levels (McManus et al., 2005; Paul et al., 2012) . These mice show disrupted circadian behavior and SCN firing rate rhythms, which did not occur in the single, isoform mutations . Therefore, we hypothesized that chronic GSK3 activation may also dampen BMAL1 expression rhythms in the hippocampus.
Double transgenic GSK3-KI mice or WT control mice were housed in DD for at least 2 weeks, and BMAL1 expression from area CA1 was quantified over a 24 hr period. Cosinor analysis revealed a significant BMAL1 expression rhythm in area CA1 from WT mice (n 5 26/time course; R 2 5 0.28, F (2, 23) 5 4.40, p 5 .02) with peak BMAL1 expression in the subjective day (mesor, 0.73 6 0.07; amplitude, 0.29 6 0.10; phase, 4.77 6 1.39; Figure 3a,b) . In GSK3-KI mice, however, BMAL1 expression failed to exhibit a significant 24 hr rhythm in CA1 (n 5 27/ time course; R 2 5 0.14, F (2, 24) 5 1.90, p 5 .17 Figure 3a ,c), suggesting that the GSK3 phosphorylation rhythm in area CA1 is necessary for normal rhythmic expression of BMAL1. There was no significant difference in overall BMAL1 expression between the WT and GSK3-KI mice (mean 6 SEM, WT: 0.72 6 0.08; KI, 0.75 6 0.08; t (51) 5 20.31, p 5 .76).
3.3 | Chronic GSK3 activation results in elevated LTP at the CA3-CA1 schaffer collateral pathway
Given that GSK3 is an important modulator of hippocampal plasticity (Hooper et al., 2007; Peineau et al., 2007) , and its activation dynamically changes over the 24 hr day in area CA1 (Figure 1) , we examined whether this p-GSK3 rhythm is critical for normal synaptic plasticity rhythms at the CA3-CA1 Schaffer collateral pathway in the hippocampus. To answer this question, we first measured LTP magnitude during the day and night from GSK3-KI and WT mice. WT mice exhibited a significant day/night difference with LTP magnitude being greater during the night, consistent with previous studies (Chaudhury et al., 2005) . 
| GSK3 inhibition reduces LTP magnitude selectively at night
Given that chronic activation of GSK3 increased LTP magnitude at both day and night recording times (Figure 4) , we sought to examine whether acute inhibition of GSK3 would suppress LTP at both times of day. Therefore, we applied a GSK3 inhibitor to hippocampal slices and recorded LTP at CA3-CA1 synapses during the day (projected ZT 2- (Hernandez et al., 2002; Hooper et al., 2007; Liu et al., 2003; Peineau et al., 2007) . Thus, this study sought to define the role of temporal regulation of GSK3 activation in hippocampal function. Here, we demonstrate three key findings. First, our study showed that GSK3b is rhythmically inactivated in the CA1 region of hippocampus in both a light/dark cycle and in constant dark conditions. Second, we found that GSK3 serves as a modulator of the hippocampal molecular clock such that chronic GSK3 activation disrupted BMAL1 rhythms while chronic GSK3 inhibition shortened PER2 periodicity.
Third, our results that GSK3 inhibition disrupted day-night differences in LTP suggest that GSK3 modulates dynamic hippocampal function over the 24 hr day.
Our results show that GSK3 phosphorylation is temporally regulated in the CA1 region of hippocampus. This result is consistent with rhythmic phosphorylation of GSK3 in the SCN (Besing et al., 2015; Fuentealba et al., 2004; Iitaka et al., 2005; Iwahana et al., 2004) . Unlike the SCN, however, only phosphorylation of GSK3b (and not GSK3a) exhibited a circadian rhythm in area CA1 of hippocampus (this study and Besing et al. (2015) ). Moreover, our analysis of mice maintained in constant darkness showed that 24 hr variation in phosphorylation of GSK3b in area CA1 was endogenously driven with a phase that peaked 3 hr later than in the SCN (Besing et al., 2015) . While phosphorylation of GSK3b did not vary over the day-night cycle in the dentate gyrus, it is possible that rhythmicity would be observed in other subfields, such as area CA3, an important area of future investigation. This 24 hr rhythm in GSK3b phosphorylation in area CA1 may be due to rhythmic expression and/or phosphorylation of Akt/AKT, the kinase which is primarily responsible for phosphorylating and inhibiting GSK3 (Hur & Zhou, 2010) . A significant circadian rhythm of Akt expression or AKT phosphorylation has been observed in the SCN (Panda et al., 2002 ) and heart (Durgan & Young, 2010) , respectively. Given the critical importance of GSK3 in hippocampal plasticity (Hooper et al., 2007; Peineau et al., 2007) , we hypothesized that this rhythm could also be important for the dynamic changes in LTP magnitude across the 24 hr day. 
| 895
To determine the importance of the GSK3 activation rhythm, we used genetic and pharmacological strategies to disrupt this rhythm by chronically activating or inhibiting GSK3, respectively. First, our results
show that inactivation-resistant GSK3 mice (GSK3-KI mice) had disrupted BMAL1 rhythmicity such that BMAL1 expression no longer exhibited a significant 24 hr rhythm in area CA1. This finding is consistent with studies investigating GSK3 regulation of the molecular clock in vitro or more recently, in the SCN (Besing et al., 2015; Sahar et al., 2010) . In particular, GSK3 may reduce BMAL1 expression indirectly through transcriptional repression via REVERBa or directly through proteosomal degradation (Sahar et al., 2010; Valnegri et al., 2011; Yin, Wang, Klein, & Lazar, 2006) . Surprisingly, we found that overall BMAL1 levels in area CA1 were unaltered by chronic GSK3 activation.
Possible explanations include temporal regulation of GSK3 intracellular localization or other compensatory mechanisms. Second, we found that chronic GSK3 inhibition shortened the cycle of the hippocampal molecular clock, consistent with evidence in other mammalian cell types and brain areas (Besing et al., 2015; Hirota et al., 2008; Li, Lu, Beesley, Loudon, & Meng, 2012) . Although it is well documented that the GSK3 inhibitor lithium lengthens the period of circadian rhythms (Abe, Herzog, & Block, 2000; Dokucu, Yu, & Taghert, 2005; Hirota et al., 2008; Iwahana, Hamada, Uchida, & Shibata, 2007; LeSauter & Silver, 1993; Li et al., 2012; Mason & Biello, 1992; Mohawk, MirandaAnaya, Tataroglu, & Menaker, 2009; Noguchi, Lo, Diemer, & Welsh, 2016; Osland et al., 2011) , our results with a more selective GSK3
inhibitor suggest that lithium-induced effects may be due to other nonspecific targets such as inositol phosphatase inhibition (Quiroz, Gould, & Manji, 2004) .
In addition to molecular clock function, we also investigated the effects of chronic GSK3 activation in regulating day-night differences in a major form of synaptic plasticity (LTP). Surprisingly, GSK3-KI mice continued to show day-night differences in the LTP magnitude at CA3-CA1 synapses. Compared to wild-type mice, GSK3-KI mice exhibited heightened LTP magnitude at both times of day. This result contrasts with prior work showing that constitutive activation of the GSK3a subunit (but not the GSK3b subunit) reduces LTP and LTD and that constitutive activation of both subunits (as in GSK3-KI mice) does not impact LTP magnitude (Polter et al., 2010; Shahab, Plattner, Irvine, Cummings, & Edwards, 2014) . One limitation of these studies and ours is the possibility of developmental and/or compensatory mechanisms in this whole body GSK3-KI mouse model. Moreover, there are methodological differences among prior studies and this work that could contribute to the variability in outcomes. These differences include the electrophysiology stimulation protocols, the use of only day-time recordings, as well as the mixed background strain of the mice in both of the prior studies (C57BL/6 3 Balb/c; McManus et al. (2005) ). In this study, all mice were backcrossed at least 10 generations to C57BL/6J
to avoid the documented effect of mouse strain on LTP magnitude (Gerlai, 2002; Jones, Peckham, Errington, Bliss, & Routtenberg, 2001; Nguyen, Abel, Kandel, & Bourtchouladze, 2000) . Finally, it is possible that the slice preparation procedure itself resynchronizes the hippocampal clock network in GSK3-KI mice and thus, any arrhythmicity potentially observed in vivo would be lost in this "deafferented" and stimulated state. In subsequent experiments, in vitro manipulations avoided this confound with potential slice preparation resetting.
Pharmacological inhibition of GSK3 has been shown to block NMDAR-dependent LTD but not LTP (Peineau et al., 2007) . Because levels of dephosphorylated (active) GSK3 are different during the day and night (Figure 1 ), we investigated whether GSK3 inhibition has time-of-day-specific effects on a major form of synaptic plasticity (LTP). To acutely manipulate GSK3 activation, we utilized pharmacological GSK3 inhibitors to assess LTP in CA3-CA1 synapses during the day and night. We found that in the presence of GSK3 inhibition, LTP magnitude was decreased selectively at night (when nocturnal mice are active, and GSK3 phosphorylation or inhibition is lowest) with no effect during the day, consistent with reports from other day-time LTP experiments (Peineau et al., 2007) . This outcome reveals the requirement of GSK3 activation for normal LTP magnitude specific only to the night. Given this result, it will be equally important for future studies to investigate whether rhythmic GSK3 activity influences day-night differences in LTD, which remain to be demonstrated in hippocampal slices.
Altogether, our results point to the importance of assessing plasticity at different times of the day when animals are typically active or inactive. Indeed, cognitive function is influenced by both time-of-day and sleep homeostasis (Wright, Lowry, & Lebourgeois, 2012) . In addition to cognition, hippocampal synaptic plasticity also varies at different times of the day (Figures 4 & 5 ; Chaudhury et al. (2005) ), suggesting that the homeostatic control of plasticity in hippocampus (Surmeier & Foehring, 2004) may be regulated by the circadian clock. Our understanding of the rhythmicity of GSK3 activation and how it modulates synaptic plasticity may provide insight into chronotherapeutic approaches in medication administration (Dallmann, Brown, & Gachon, 
